BioMarin to Host Fourth Quarter and Full Year 2016 Financial Results Conference Call and Webcast on Thursday, February 23 at 4:30pm ET

SAN RAFAEL, Calif., Feb. 7, 2017/PRNewswire / -- BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) today announced that Jean-Jacques Bienaimé, Chairman and Chief Executive Officer of BioMarin, will host a conference call and webcast on Thursday, February 23, at 4:30 p.m. ETto discuss fourth quarter and full year 2016 financial results and provide a general business update.

Dial-in Number
U.S. / Canada Dial-in Number: (866) 502-9859
International Dial-in Number: (574) 990-1362
Conference ID: 60631310

Replay Dial-in Number: (855) 859-2056
Replay International Dial-in Number: (404) 537-3406
Conference ID: 60631310

Interested parties may access a live audio webcast of the conference call via the investor section of the BioMarin website, www.biomarin.com. A replay of the call will be archived on the site for one week following the call.

About BioMarin
 BioMarin is a global biotechnology company that develops and commercializes innovative therapies for patients with serious and life-threatening rare and ultra-rare genetic diseases. The company's portfolio consists of five commercialized products and multiple clinical and pre-clinical product candidates. For additional information, please visit www.biomarin.com.

Contacts:

Investors

Media

Traci McCarty

Debra Charlesworth

BioMarin Pharmaceutical Inc.

BioMarin Pharmaceutical Inc.

(415) 455-7558

(415) 455-7451

SOURCE BioMarin Pharmaceutical Inc.

BioMarin Pharmaceutical Inc. published this content on 07 February 2017 and is solely responsible for the information contained herein.
Distributed by Public, unedited and unaltered, on 07 March 2017 15:47:13 UTC.

Original documenthttp://investors.biomarin.com/2017-02-07-BioMarin-to-Host-Fourth-Quarter-and-Full-Year-2016-Financial-Results-Conference-Call-and-Webcast-on-Thursday-February-23-at-4-30pm-ET

Public permalinkhttp://www.publicnow.com/view/E85D2D3EF7E3B6E7CC5D2DB9E08FC354A0F81F16